Kras and Hras—what is the difference?

Article metrics

Kras, Hras or Nras mutations occur at varying frequencies across different tumors in humans for unknown reasons. A new study shows that, in mice, locus-specific regulatory elements determine whether mutations in Hras or Kras will predominate in lung and skin tumors.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Bos, J.L. Cancer Res. 49, 4682–4689 (1989).

  2. 2

    To, M.D. et al. Nat. Genet. 40, 1240–1244 (2008).

  3. 3

    Kohl, N.E. et al. Nat. Med. 1, 792–797 (1995).

  4. 4

    Johnson, B.E. & Heymach, J.V. Clin. Cancer Res. 10, 4254s–4257s (2004).

  5. 5

    Mijimolle, N. et al. Cancer Cell 7, 313–324 (2005).

  6. 6

    Konstantinopoulos, P.A., Karamouzis, M.V. & Papavassiliou, A.G. Nat. Rev. Drug Discov. 6, 541–555 (2007).

  7. 7

    Hancock, J.F. Nat. Rev. Mol. Cell Biol. 4, 373–384 (2003).

  8. 8

    Potenza, N. et al. EMBO Rep. 6, 432–437 (2005).

  9. 9

    Zhang, Z. et al. Nat. Genet. 29, 25–33 (2001).

  10. 10

    Johnson, L. et al. Nature 410, 1111–1116 (2001).

  11. 11

    Patek, C.E. et al. Exp. Cell Res. 314, 1105–1114 (2008).

  12. 12

    Plowman, S.J. et al. Mol. Cell. Biol. 23, 9245–9250 (2003).

  13. 13

    Patek, C.E. et al. BMC Gastroenterol. 8, 24 (2008).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading